NM_001001331.4:c.2703+9G>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001001331.4(ATP2B2):c.2703+9G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.434 in 1,613,588 control chromosomes in the GnomAD database, including 156,882 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.37 ( 11630 hom., cov: 33)
Exomes 𝑓: 0.44 ( 145252 hom. )
Consequence
ATP2B2
NM_001001331.4 intron
NM_001001331.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.497
Publications
11 publications found
Genes affected
ATP2B2 (HGNC:815): (ATPase plasma membrane Ca2+ transporting 2) The protein encoded by this gene belongs to the family of P-type primary ion transport ATPases characterized by the formation of an aspartyl phosphate intermediate during the reaction cycle. These enzymes remove bivalent calcium ions from eukaryotic cells against very large concentration gradients and play a critical role in intracellular calcium homeostasis. The mammalian plasma membrane calcium ATPase isoforms are encoded by at least four separate genes and the diversity of these enzymes is further increased by alternative splicing of transcripts. The expression of different isoforms and splice variants is regulated in a developmental, tissue- and cell type-specific manner, suggesting that these pumps are functionally adapted to the physiological needs of particular cells and tissues. This gene encodes the plasma membrane calcium ATPase isoform 2. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
ATP2B2 Gene-Disease associations (from GenCC):
- hearing loss, autosomal dominant 82Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- autosomal recessive nonsyndromic hearing loss 12Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
- neurodevelopmental disorderInheritance: AD Classification: STRONG Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 3-10345375-C-A is Benign according to our data. Variant chr3-10345375-C-A is described in ClinVar as Benign. ClinVar VariationId is 1247918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.528 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ATP2B2 | NM_001001331.4 | c.2703+9G>T | intron_variant | Intron 18 of 22 | ENST00000360273.7 | NP_001001331.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ATP2B2 | ENST00000360273.7 | c.2703+9G>T | intron_variant | Intron 18 of 22 | 5 | NM_001001331.4 | ENSP00000353414.2 |
Frequencies
GnomAD3 genomes AF: 0.366 AC: 55629AN: 152018Hom.: 11635 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
55629
AN:
152018
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.451 AC: 112944AN: 250682 AF XY: 0.455 show subpopulations
GnomAD2 exomes
AF:
AC:
112944
AN:
250682
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.441 AC: 643989AN: 1461450Hom.: 145252 Cov.: 48 AF XY: 0.444 AC XY: 322761AN XY: 727028 show subpopulations
GnomAD4 exome
AF:
AC:
643989
AN:
1461450
Hom.:
Cov.:
48
AF XY:
AC XY:
322761
AN XY:
727028
show subpopulations
African (AFR)
AF:
AC:
4814
AN:
33476
American (AMR)
AF:
AC:
26004
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
AC:
9495
AN:
26130
East Asian (EAS)
AF:
AC:
22287
AN:
39694
South Asian (SAS)
AF:
AC:
48238
AN:
86242
European-Finnish (FIN)
AF:
AC:
23488
AN:
53380
Middle Eastern (MID)
AF:
AC:
2588
AN:
5762
European-Non Finnish (NFE)
AF:
AC:
481722
AN:
1111684
Other (OTH)
AF:
AC:
25353
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
19119
38238
57356
76475
95594
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
14794
29588
44382
59176
73970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.366 AC: 55633AN: 152138Hom.: 11630 Cov.: 33 AF XY: 0.373 AC XY: 27764AN XY: 74364 show subpopulations
GnomAD4 genome
AF:
AC:
55633
AN:
152138
Hom.:
Cov.:
33
AF XY:
AC XY:
27764
AN XY:
74364
show subpopulations
African (AFR)
AF:
AC:
6302
AN:
41544
American (AMR)
AF:
AC:
7764
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
1251
AN:
3468
East Asian (EAS)
AF:
AC:
2659
AN:
5142
South Asian (SAS)
AF:
AC:
2633
AN:
4826
European-Finnish (FIN)
AF:
AC:
4555
AN:
10596
Middle Eastern (MID)
AF:
AC:
138
AN:
294
European-Non Finnish (NFE)
AF:
AC:
29045
AN:
67950
Other (OTH)
AF:
AC:
817
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1714
3427
5141
6854
8568
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
534
1068
1602
2136
2670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Nov 29, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.